Stock Events

Stock Events

HeartSciences 

$0.073300
35
+$0.01+18.42% Friday 19:39
+$0.00+0%Friday 20:00After hours

Statistics

Day High
0.0733
Day Low
0.0733
52W High
0.0733
52W Low
0.06
Volume
126
Avg. Volume
-
Mkt Cap
241,182.66
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22JulExpected
Q3 2024
Q4 2024
Q2 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.55
-1.92
-1.29
-0.66
Expected EPS
-0.66
Actual EPS
N/A

Financials

-219,125%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
4,000Revenue
-8.77MNet Income

Analyst Ratings

8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSCSW. It's not an investment recommendation.
Apple
5
AAPL
Realty Income
5
O
Palantir Technologies
5
PLTR
Microvast
5
MVST

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap166.17B
Abbott Laboratories offers a broad range of cardiovascular devices and diagnostics, directly competing with HSCS's heart testing technologies.
Medtronic
MDT
Mkt Cap106.49B
Medtronic plc specializes in medical devices for cardiac and vascular diseases, offering products that compete with HSCS's heart diagnostic solutions.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation provides innovative medical solutions, including cardiovascular devices that compete with HSCS's offerings.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its medical device segment, offers products for cardiovascular care, competing with HSCS's heart diagnostics.
Koninklijke Philips N.V.
PHG
Mkt Cap26.96B
Royal Philips offers advanced cardiac diagnostics and monitoring solutions, competing with HSCS in the heart test market.
GE Aerospace
GE
Mkt Cap394.44B
General Electric, through its healthcare division, provides medical imaging and monitoring technologies for cardiovascular care, competing with HSCS.
Siemens
SIEGY
Mkt Cap243.25B
Siemens Healthineers offers a wide range of diagnostic imaging and laboratory diagnostics, including cardiovascular testing, competing with HSCS.
Baxter International
BAX
Mkt Cap11.7B
Baxter International Inc. provides a range of medical devices and software for health care, including products for cardiovascular support, competing with HSCS.
Becton Dickinson
BDX
Mkt Cap43.56B
Becton, Dickinson and Company offers medical devices and technology, including for cardiovascular care, competing with HSCS's heart diagnostics.

About

Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.
Show more...
CEO
Mr. Andrew Simpson
Employees
15
Country
United States
ISIN
US42254E1120

Listings

XNAS
US
HSCSW
XNAS
US
HSCS
BOATS
BOATS
HSCS.BOATS

0 Comments

Share your thoughts

FAQ

What is HeartSciences stock price today?▼
The current price of HSCSW is $0.07 USD — it has increased by +18.42% in the past 24 hours. Watch HeartSciences stock price performance more closely on the chart.
What is HeartSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange HeartSciences stocks are traded under the ticker HSCSW.
What is HeartSciences market cap?▼
Today HeartSciences has the market capitalization of 241,182.66
When is the next HeartSciences earnings date?▼
HeartSciences is going to release the next earnings report on July 22, 2026.
What were HeartSciences earnings last quarter?▼
HSCSW earnings for the last quarter are -0.71 USD per share, whereas the estimation was -0.88 USD resulting in a +19.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HeartSciences revenue for the last year?▼
HeartSciences revenue for the last year amounts to 4,000 USD.
What is HeartSciences net income for the last year?▼
HSCSW net income for the last year is -8.77M USD.
How many employees does HeartSciences have?▼
As of July 12, 2026, the company has 15 employees.
In which sector is HeartSciences located?▼
HeartSciences operates in the Health & Wellness sector.
When did HeartSciences complete a stock split?▼
The last stock split for HeartSciences was on May 17, 2024 with a ratio of 1:100.
Where is HeartSciences headquartered?▼
HeartSciences is headquartered in Southlake, United States.